Hong Kong stock market anomaly | BeiKai Medicine-B (02105.HK) opened over 8% higher and announced multiple clinical research results including LAE102 at the ADA 2025 conference.

According to the Wisdom Financial APP, Lai Kai Pharmaceutical-B (02105.HK) opened more than 8% higher, rising 8.63% to 20.4 Hong Kong dollars as of the time of publication, with a trading volume of 6.222 million Hong Kong dollars.